Pharmacokinetics of Ambrisentan, a Novel Drug for Treatment of Pulmonary Arterial Hypertension (PAH), in Japanese Subjects
Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.41.301
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2010
Authors
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics